[1] |
Lion T.Adenovirus infections in immunocompetent and immunocompromised patients[J]. Clin Microbiol Rev, 2014,27(3):441-462.
|
[2] |
Williams BG, Gouws E, Boschi-Pinto C, et al.Estimates of world-wide distribution of child deaths from acute respiratory infections[J]. Lancet Infect Dis, 2002,2(1):25-32.
|
[3] |
攸小瑾, 曹蓝, 陈艺韵, 等. 2017年广州市6种常见非流感呼吸道病毒感染监测分析[J]. 华南预防医学, 2019,45(1):48-51.
|
[4] |
Yu Z, Zeng Z, Zhang J, et al.Fatal community-acquired pneumonia in children caused by re-emergent human Adenovirus 7d associated with higher severity of illness and fatality rate[J]. Sci Rep, 2016,6(1):1-12.
|
[5] |
胡凤华, 曲东, 任晓旭, 等. 儿童3型和7型腺病毒肺炎47例临床分析[J]. 中华医学杂志, 2012,92(48):3393-3397.
|
[6] |
钟华文. 儿童腺病毒肺炎降钙素原变化分析[J]. 中外医疗, 2019,38(36):71-73.
|
[7] |
付笑迎, 杨方华, 孙丽芳, 等. 血细胞常规、C反应蛋白及降钙素原联合检测诊断儿童病毒感染性疾病的临床意义[J]. 国际检验医学杂志, 2015,36(23):3390-3392.
|
[8] |
Kawasaki Y, Hosoya M, Katayose M, et al.Correlation between serum interleukin 6 and C-reactive protein concentrations in patients with adenoviral respiratory infection[J]. Pediatr Infect Dis J, 2002,21(5):370-374.
|
[9] |
全军传染病专业委员会,新突发传染病中西医临床救治课题组. 腺病毒感染诊疗指南[J].解放军医学杂志, 2013,38(7):529-534.
|
[10] |
胡亚美,江载芳. 诸福棠实用儿科学[M]. 8版. 北京:人民卫生出版社, 2015:1253-1272.
|
[11] |
李昌崇,尚云晓,沈叙庄,等. 儿童社区获得性肺炎管理指南(2013修订)(上)[J].中华儿科杂志,2013,51(10):745-752.
|
[12] |
陶珊. 小儿重症肺炎不同病原抗原及抗体IgM抗体检测特点及流行趋势分析[J].分子诊断与治疗杂志,2020,12(4):492-496.
|
[13] |
李映来,王曼,冯志锋,等.广东省中山市急性发热呼吸道症候群病毒病原学研究[J].中国热带医学,2020,20(12):1179-1182.
|
[14] |
Patel JA, Nair S, Ochoa EE, et al.Interleukin-6 -174 and tumor necrosis factor α-308 polymorphisms enhance cytokine production by human macrophages exposed to respiratory viruses[J]. Interferon Cytokine Res, 2010,30(12):917-921.
|
[15] |
Wo Y, Lu QB, Huang DD, et al.Epidemical features of HAdV-3 and HAdV-7 in pediatric pneumonia in Chongqing, China[J]. Arch Virol, 2015,160(3):633-638.
|
[16] |
Whang KT, Vath SD, Becker KL, et al.Procalcitonin and proinflammatory cytokine in interactions in sepsis[J]. Shock, 1999,12(4):268-273.
|
[17] |
Elenius V, Peltola V, Ruuskanen O, et al.Plasma procalcitonin levels in children with adenovirus infection[J]. Arch Dis Child, 2012,97(6):582-583.
|
[18] |
Masiá M, Gutiérrez F, Shum C, et al.Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index[J]. Chest, 2005,128(4):2223-2229.
|
[19] |
Fernández JA, Tapia L, Palomino MA, et al.Plasma interferon-gamma, interleukin-10 and soluble markers of immune activation in infants with primary adenovirus (ADV) and respiratory syncytial virus (RSV) infection[J]. Eur Cytokine Netw,2015,16(1):35-40.
|
[20] |
Vasileva D, Badawi A.C-reactive protein as a biomarker of severe H1N1 influenza[J]. Inflamm Res, 2019,68(1):39-46.
|